Stocks
Regeneron Pharmaceuticals, Inc.REGN
NASDAQHealthcareBiotechnology$745.77-0.11%
A biotechnology developer focused on monoclonal antibody therapies and other biologic medicines used to treat conditions including eye disease, cancer, and inflammatory disorders. Its commercial portfolio includes blockbuster drugs such as Eylea for retinal diseases and Dupixent, partnered with Sano...
Market Cap: $77.5B52W Range: $476.49 – $821.11
This page tracks all publicly disclosed congressional trades in Regeneron Pharmaceuticals, Inc. (REGN), a company in the Healthcare sector. 11 members of Congress have disclosed trades in this stock, including 20 purchases and 30 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
50
Unique Politicians
11
Buys
20
Sells
30
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-12 | Julia Letlow | buy | $1K – $15K |
| 2026-01-29 | Rohit Khanna | sell | $1K – $15K |